HEATHER JARRARD: Open Payments
NPI 1215270822 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 16 payments from 13 companies in 2025. Trend: 2023 $110 · 2024 $199 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Boston Scientific Corporation | 1 | $33 |
| BridgeBio Pharma, Inc. | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Abbott Laboratories | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: SAPIEN 3 Ultra RESILIA, WATCHMAN FLX, Attruby, LifeVest, LEQVIO, JARDIANCE, NEXLETOL, CARDIOMEMS.
Industry payments across MN — which companies pay providers there.
